HopeStage
Back to all studies
RecruitingNCT06835504

Ketamine or morphine for acute pain in children

About this titleRead the official source — NCT06835504
Medication studyAges 6–17United StatesPTSD
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 17 years.

What will I do during this study?

Depending on the assigned group, the study provides ketamine or morphine through a vein for pain treatment.

Listed locations
Los Angeles and 7 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 17, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
1,010
Sponsor
Columbia University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 6 Years to 17 Years
Official registry ID
NCT06835504
Official title
Show the full official title

Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain

Recruitment & locations

Currently recruiting

Los Angeles · Sacramento · Wilmington

5 more locations
  • Atlanta
  • New York
  • Pittsburgh
  • Seattle
  • Milwaukee

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Columbia University, a university.

Does this study involve medication?

Yes. The study involves medication, including Ketamine hydrochloride and Morphine sulphate.

Who can participate?

Listed age limits: 6 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies